咽頭がん治療薬の世界市場2024-2028

■ 英語タイトル:Global Throat Cancer Therapeutics Market 2024-2028

調査会社Technavio社が発行したリサーチレポート(データ管理コード:IRTNTR73577-24)■ 発行会社/調査会社:Technavio
■ 商品コード:IRTNTR73577-24
■ 発行日:2023年12月15日
■ 調査対象地域:グローバル
■ 産業分野:医療
■ ページ数:約120
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[咽頭がん治療薬の世界市場2024-2028]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

咽頭がん治療薬の世界市場2024〜2028年咽頭がん治療薬市場は2023〜2028年に23億3000万米ドル成長し、予測期間中のCAGRは7.51%で加速すると予測されます。当レポートでは、咽頭がん治療薬市場の全体的な分析、市場規模および予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析も提供しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。咽頭癌の発生率の増加、タバコ製品の使用の増加、咽頭癌のリスク要因の増加が市場を牽引しています。

Technavio社の咽頭がん治療薬市場は以下のように分類されます:
タイプ別
- 咽頭がん
- 喉頭がん

流通チャネル別
- オフライン
- オンライン

地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本調査では、今後数年間の咽頭がん治療薬市場の成長を促進する主な理由の1つとして、ベンダーの戦略的提携の拡大を挙げています。また、患者支援プログラムの採用増加や咽頭がん治療薬の強力なパイプラインは、市場の大きな需要につながります。

この調査レポートは、咽頭がん治療薬市場を調査・分析した結果をまとめたものです:
- 咽頭がん治療薬の市場規模
- 咽頭がん治療薬市場予測
- 咽頭がん治療薬市場の産業分析

強固なベンダー分析は、クライアントが市場での地位を向上できるように設計されており、これに沿って本レポートでは、Adlai Nortye Ltd., Amgen Inc., AstraZeneca Plc, Bayer AG, Bristol Myers Squibb Co., Celldex Therapeutics Inc., Clinigen Group Plc, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Merck KGaA, Moderna Inc, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., and Sanofi SA.などを分析しています。また、咽頭がん治療薬市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。当レポートでは、主要ベンダーの分析に加え、包括的な市場とベンダーの状況を掲載しています。

当出版社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細な姿を提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

1 エグゼクティブサマリー
2 市場概況
3 市場規模
4 過去の市場規模
5 ファイブフォース分析
6 世界の咽頭がん治療薬市場規模:種類別分析
7 世界の咽頭がん治療薬市場規模:流通チャネル別分析
8 顧客状況
9 地域別状況
10 推進要因・課題・動向
11 企業状況
12 企業分析
13 付録

世界の市場調査レポート販売サイト(H&Iグローバルリサーチ株式会社運営)
*** レポート目次(コンテンツ)***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global throat cancer therapeutics market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global throat cancer therapeutics market 2018 – 2022 ($ billion)
o 4.2 Type Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – Type Segment 2018 – 2022 ($ billion)
o 4.3 Distribution Channel Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – Distribution Channel Segment 2018 – 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 – 2022
o Exhibit 22: Historic Market Size – Country Segment 2018 – 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type – Market share 2023-2028 (%)
o Exhibit 31: Data Table on Type – Market share 2023-2028 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Pharyngeal cancer – Market size and forecast 2023-2028
o Exhibit 34: Chart on Pharyngeal cancer – Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Pharyngeal cancer – Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Pharyngeal cancer – Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Pharyngeal cancer – Year-over-year growth 2023-2028 (%)
o 6.4 Laryngeal cancer – Market size and forecast 2023-2028
o Exhibit 38: Chart on Laryngeal cancer – Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Laryngeal cancer – Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Laryngeal cancer – Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Laryngeal cancer – Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ billion)
o Exhibit 43: Data Table on Market opportunity by Type ($ billion)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 44: Chart on Distribution Channel – Market share 2023-2028 (%)
o Exhibit 45: Data Table on Distribution Channel – Market share 2023-2028 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 46: Chart on Comparison by Distribution Channel
o Exhibit 47: Data Table on Comparison by Distribution Channel
o 7.3 Offline – Market size and forecast 2023-2028
o Exhibit 48: Chart on Offline – Market size and forecast 2023-2028 ($ billion)
o Exhibit 49: Data Table on Offline – Market size and forecast 2023-2028 ($ billion)
o Exhibit 50: Chart on Offline – Year-over-year growth 2023-2028 (%)
o Exhibit 51: Data Table on Offline – Year-over-year growth 2023-2028 (%)
o 7.4 Online – Market size and forecast 2023-2028
o Exhibit 52: Chart on Online – Market size and forecast 2023-2028 ($ billion)
o Exhibit 53: Data Table on Online – Market size and forecast 2023-2028 ($ billion)
o Exhibit 54: Chart on Online – Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Online – Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Distribution Channel
o Exhibit 56: Market opportunity by Distribution Channel ($ billion)
o Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share by geography 2023-2028 (%)
o Exhibit 60: Data Table on Market share by geography 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2023-2028
o Exhibit 63: Chart on North America – Market size and forecast 2023-2028 ($ billion)
o Exhibit 64: Data Table on North America – Market size and forecast 2023-2028 ($ billion)
o Exhibit 65: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 66: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.4 Europe – Market size and forecast 2023-2028
o Exhibit 67: Chart on Europe – Market size and forecast 2023-2028 ($ billion)
o Exhibit 68: Data Table on Europe – Market size and forecast 2023-2028 ($ billion)
o Exhibit 69: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.5 Asia – Market size and forecast 2023-2028
o Exhibit 71: Chart on Asia – Market size and forecast 2023-2028 ($ billion)
o Exhibit 72: Data Table on Asia – Market size and forecast 2023-2028 ($ billion)
o Exhibit 73: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 75: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
o Exhibit 76: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 79: Chart on US – Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on US – Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 India – Market size and forecast 2023-2028
o Exhibit 83: Chart on India – Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on India – Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on India – Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on India – Year-over-year growth 2023-2028 (%)
o 9.9 Hungary – Market size and forecast 2023-2028
o Exhibit 87: Chart on Hungary – Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on Hungary – Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on Hungary – Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Hungary – Year-over-year growth 2023-2028 (%)
o 9.10 Canada – Market size and forecast 2023-2028
o Exhibit 91: Chart on Canada – Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on Canada – Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on Canada – Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Canada – Year-over-year growth 2023-2028 (%)
o 9.11 Poland – Market size and forecast 2023-2028
o Exhibit 95: Chart on Poland – Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on Poland – Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on Poland – Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Poland – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity by geography
o Exhibit 99: Market opportunity by geography ($ billion)
o Exhibit 100: Data Tables on Market opportunity by geography ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 Adlai Nortye Ltd.
o Exhibit 107: Adlai Nortye Ltd. – Overview
o Exhibit 108: Adlai Nortye Ltd. – Product / Service
o Exhibit 109: Adlai Nortye Ltd. – Key offerings
o 12.4 Amgen Inc.
o Exhibit 110: Amgen Inc. – Overview
o Exhibit 111: Amgen Inc. – Product / Service
o Exhibit 112: Amgen Inc. – Key offerings
o 12.5 AstraZeneca Plc
o Exhibit 113: AstraZeneca Plc – Overview
o Exhibit 114: AstraZeneca Plc – Product / Service
o Exhibit 115: AstraZeneca Plc – Key news
o Exhibit 116: AstraZeneca Plc – Key offerings
o 12.6 Bayer AG
o Exhibit 117: Bayer AG – Overview
o Exhibit 118: Bayer AG – Business segments
o Exhibit 119: Bayer AG – Key news
o Exhibit 120: Bayer AG – Key offerings
o Exhibit 121: Bayer AG – Segment focus
o 12.7 Bristol Myers Squibb Co.
o Exhibit 122: Bristol Myers Squibb Co. – Overview
o Exhibit 123: Bristol Myers Squibb Co. – Product / Service
o Exhibit 124: Bristol Myers Squibb Co. – Key news
o Exhibit 125: Bristol Myers Squibb Co. – Key offerings
o 12.8 Celldex Therapeutics Inc.
o Exhibit 126: Celldex Therapeutics Inc. – Overview
o Exhibit 127: Celldex Therapeutics Inc. – Product / Service
o Exhibit 128: Celldex Therapeutics Inc. – Key offerings
o 12.9 Clinigen Group Plc
o Exhibit 129: Clinigen Group Plc – Overview
o Exhibit 130: Clinigen Group Plc – Product / Service
o Exhibit 131: Clinigen Group Plc – Key offerings
o 12.10 Eli Lilly and Co.
o Exhibit 132: Eli Lilly and Co. – Overview
o Exhibit 133: Eli Lilly and Co. – Product / Service
o Exhibit 134: Eli Lilly and Co. – Key news
o Exhibit 135: Eli Lilly and Co. – Key offerings
o 12.11 F. Hoffmann La Roche Ltd.
o Exhibit 136: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 137: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 138: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 139: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 140: F. Hoffmann La Roche Ltd. – Segment focus
o 12.12 Merck KGaA
o Exhibit 141: Merck KGaA – Overview
o Exhibit 142: Merck KGaA – Business segments
o Exhibit 143: Merck KGaA – Key news
o Exhibit 144: Merck KGaA – Key offerings
o Exhibit 145: Merck KGaA – Segment focus
o 12.13 Moderna Inc
o Exhibit 146: Moderna Inc – Overview
o Exhibit 147: Moderna Inc – Product / Service
o Exhibit 148: Moderna Inc – Key offerings
o 12.14 Novartis AG
o Exhibit 149: Novartis AG – Overview
o Exhibit 150: Novartis AG – Business segments
o Exhibit 151: Novartis AG – Key offerings
o Exhibit 152: Novartis AG – Segment focus
o 12.15 Pfizer Inc.
o Exhibit 153: Pfizer Inc. – Overview
o Exhibit 154: Pfizer Inc. – Product / Service
o Exhibit 155: Pfizer Inc. – Key news
o Exhibit 156: Pfizer Inc. – Key offerings
o 12.16 Regeneron Pharmaceuticals Inc.
o Exhibit 157: Regeneron Pharmaceuticals Inc. – Overview
o Exhibit 158: Regeneron Pharmaceuticals Inc. – Product / Service
o Exhibit 159: Regeneron Pharmaceuticals Inc. – Key offerings
o 12.17 Sanofi SA
o Exhibit 160: Sanofi SA – Overview
o Exhibit 161: Sanofi SA – Business segments
o Exhibit 162: Sanofi SA – Key news
o Exhibit 163: Sanofi SA – Key offerings
o Exhibit 164: Sanofi SA – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 165: Inclusions checklist
o Exhibit 166: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 167: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 168: Research methodology
o Exhibit 169: Validation techniques employed for market sizing
o Exhibit 170: Information sources
o 13.5 List of abbreviations
o Exhibit 171: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Type
Exhibits6: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size – Data Table on global throat cancer therapeutics market 2018 – 2022 ($ billion)
Exhibits19: Historic Market Size – Type Segment 2018 – 2022 ($ billion)
Exhibits20: Historic Market Size – Distribution Channel Segment 2018 – 2022 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2018 – 2022 ($ billion)
Exhibits22: Historic Market Size – Country Segment 2018 – 2022 ($ billion)
Exhibits23: Five forces analysis – Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition – Five forces 2023 and 2028
Exhibits30: Chart on Type – Market share 2023-2028 (%)
Exhibits31: Data Table on Type – Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Pharyngeal cancer – Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Pharyngeal cancer – Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Pharyngeal cancer – Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Pharyngeal cancer – Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Laryngeal cancer – Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Laryngeal cancer – Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Laryngeal cancer – Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Laryngeal cancer – Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Type ($ billion)
Exhibits43: Data Table on Market opportunity by Type ($ billion)
Exhibits44: Chart on Distribution Channel – Market share 2023-2028 (%)
Exhibits45: Data Table on Distribution Channel – Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Distribution Channel
Exhibits47: Data Table on Comparison by Distribution Channel
Exhibits48: Chart on Offline – Market size and forecast 2023-2028 ($ billion)
Exhibits49: Data Table on Offline – Market size and forecast 2023-2028 ($ billion)
Exhibits50: Chart on Offline – Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Offline – Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Online – Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Online – Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Online – Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Online – Year-over-year growth 2023-2028 (%)
Exhibits56: Market opportunity by Distribution Channel ($ billion)
Exhibits57: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share by geography 2023-2028 (%)
Exhibits60: Data Table on Market share by geography 2023-2028 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America – Market size and forecast 2023-2028 ($ billion)
Exhibits64: Data Table on North America – Market size and forecast 2023-2028 ($ billion)
Exhibits65: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits66: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits67: Chart on Europe – Market size and forecast 2023-2028 ($ billion)
Exhibits68: Data Table on Europe – Market size and forecast 2023-2028 ($ billion)
Exhibits69: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Asia – Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on Asia – Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on US – Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on US – Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on India – Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on India – Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on India – Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on India – Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Hungary – Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Hungary – Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Hungary – Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Hungary – Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Canada – Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Canada – Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Canada – Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Canada – Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Poland – Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on Poland – Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on Poland – Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Poland – Year-over-year growth 2023-2028 (%)
Exhibits99: Market opportunity by geography ($ billion)
Exhibits100: Data Tables on Market opportunity by geography ($ billion)
Exhibits101: Impact of drivers and challenges in 2023 and 2028
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Adlai Nortye Ltd. – Overview
Exhibits108: Adlai Nortye Ltd. – Product / Service
Exhibits109: Adlai Nortye Ltd. – Key offerings
Exhibits110: Amgen Inc. – Overview
Exhibits111: Amgen Inc. – Product / Service
Exhibits112: Amgen Inc. – Key offerings
Exhibits113: AstraZeneca Plc – Overview
Exhibits114: AstraZeneca Plc – Product / Service
Exhibits115: AstraZeneca Plc – Key news
Exhibits116: AstraZeneca Plc – Key offerings
Exhibits117: Bayer AG – Overview
Exhibits118: Bayer AG – Business segments
Exhibits119: Bayer AG – Key news
Exhibits120: Bayer AG – Key offerings
Exhibits121: Bayer AG – Segment focus
Exhibits122: Bristol Myers Squibb Co. – Overview
Exhibits123: Bristol Myers Squibb Co. – Product / Service
Exhibits124: Bristol Myers Squibb Co. – Key news
Exhibits125: Bristol Myers Squibb Co. – Key offerings
Exhibits126: Celldex Therapeutics Inc. – Overview
Exhibits127: Celldex Therapeutics Inc. – Product / Service
Exhibits128: Celldex Therapeutics Inc. – Key offerings
Exhibits129: Clinigen Group Plc – Overview
Exhibits130: Clinigen Group Plc – Product / Service
Exhibits131: Clinigen Group Plc – Key offerings
Exhibits132: Eli Lilly and Co. – Overview
Exhibits133: Eli Lilly and Co. – Product / Service
Exhibits134: Eli Lilly and Co. – Key news
Exhibits135: Eli Lilly and Co. – Key offerings
Exhibits136: F. Hoffmann La Roche Ltd. – Overview
Exhibits137: F. Hoffmann La Roche Ltd. – Business segments
Exhibits138: F. Hoffmann La Roche Ltd. – Key news
Exhibits139: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits140: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits141: Merck KGaA – Overview
Exhibits142: Merck KGaA – Business segments
Exhibits143: Merck KGaA – Key news
Exhibits144: Merck KGaA – Key offerings
Exhibits145: Merck KGaA – Segment focus
Exhibits146: Moderna Inc – Overview
Exhibits147: Moderna Inc – Product / Service
Exhibits148: Moderna Inc – Key offerings
Exhibits149: Novartis AG – Overview
Exhibits150: Novartis AG – Business segments
Exhibits151: Novartis AG – Key offerings
Exhibits152: Novartis AG – Segment focus
Exhibits153: Pfizer Inc. – Overview
Exhibits154: Pfizer Inc. – Product / Service
Exhibits155: Pfizer Inc. – Key news
Exhibits156: Pfizer Inc. – Key offerings
Exhibits157: Regeneron Pharmaceuticals Inc. – Overview
Exhibits158: Regeneron Pharmaceuticals Inc. – Product / Service
Exhibits159: Regeneron Pharmaceuticals Inc. – Key offerings
Exhibits160: Sanofi SA – Overview
Exhibits161: Sanofi SA – Business segments
Exhibits162: Sanofi SA – Key news
Exhibits163: Sanofi SA – Key offerings
Exhibits164: Sanofi SA – Segment focus
Exhibits165: Inclusions checklist
Exhibits166: Exclusions checklist
Exhibits167: Currency conversion rates for US$
Exhibits168: Research methodology
Exhibits169: Validation techniques employed for market sizing
Exhibits170: Information sources
Exhibits171: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(IRTNTR73577-24 )"咽頭がん治療薬の世界市場2024-2028" (英文:Global Throat Cancer Therapeutics Market 2024-2028)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。